7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Hyperostosis D015576 1 associated lipids
Hip Dislocation D006617 1 associated lipids
Rupture, Spontaneous D012422 1 associated lipids
Malocclusion, Angle Class I D008311 1 associated lipids
Severe Combined Immunodeficiency D016511 1 associated lipids
Peri-Implantitis D057873 1 associated lipids
Adrenocortical Adenoma D018246 1 associated lipids
Hyperparathyroidism, Primary D049950 1 associated lipids
Breast Neoplasms, Male D018567 1 associated lipids
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative D054438 1 associated lipids
Hashimoto Disease D050031 1 associated lipids
Legg-Calve-Perthes Disease D007873 1 associated lipids
Fluorosis, Dental D009050 1 associated lipids
Bone Demineralization, Pathologic D018488 1 associated lipids
POEMS Syndrome D016878 1 associated lipids
Fibroma, Ossifying D018214 1 associated lipids
Osteolysis, Essential D010015 1 associated lipids
Dentin Dysplasia D003805 1 associated lipids
Neoplasms, Squamous Cell D018307 1 associated lipids
Osteoporotic Fractures D058866 1 associated lipids
Hemangioma, Capillary D018324 1 associated lipids
Prediabetic State D011236 1 associated lipids
Cleidocranial Dysplasia D002973 1 associated lipids
Neoplastic Syndromes, Hereditary D009386 1 associated lipids
Scleroderma, Limited D045745 1 associated lipids
Rheumatic Fever D012213 1 associated lipids
Chronic Periodontitis D055113 1 associated lipids
Intracranial Hemorrhage, Traumatic D020198 1 associated lipids
Vestibulocochlear Nerve Diseases D000160 1 associated lipids
Dental Pulp Exposure D003789 1 associated lipids
Dental Occlusion, Traumatic D003769 1 associated lipids
Arthropathy, Neurogenic D001177 1 associated lipids
Giant Cell Tumor of Bone D018212 1 associated lipids
Hemarthrosis D006395 1 associated lipids
Cherubism D002636 1 associated lipids
Bisphosphonate-Associated Osteonecrosis of the Jaw D059266 1 associated lipids
Mandibular Injuries D008338 1 associated lipids
Diabetic Foot D017719 1 associated lipids
Emphysema D004646 1 associated lipids
Arteriolosclerosis D050379 1 associated lipids
Tooth Ankylosis D020254 1 associated lipids
Spondylarthropathies D025242 1 associated lipids
Ankylosis D000844 1 associated lipids
Jaw, Edentulous D007575 1 associated lipids
Chondrocalcinosis D002805 1 associated lipids
Lymphangioleiomyomatosis D018192 1 associated lipids
Carcinoid Heart Disease D002275 1 associated lipids
Alphavirus Infections D018354 1 associated lipids
Foot Injuries D018409 1 associated lipids
Synovitis, Pigmented Villonodular D013586 1 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Schinke T and Karsenty G Vascular calcification--a passive process in need of inhibitors. 2000 Nephrol. Dial. Transplant. pmid:10978374
Lorenzo J Interactions between immune and bone cells: new insights with many remaining questions. 2000 J. Clin. Invest. pmid:10995785
Teng YT et al. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. 2000 J. Clin. Invest. pmid:10995794
Børset M et al. Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins. 2000 Blood pmid:11001907
Kobayashi Y et al. Force-induced osteoclast apoptosis in vivo is accompanied by elevation in transforming growth factor beta and osteoprotegerin expression. 2000 J. Bone Miner. Res. pmid:11028444
Zhang YH et al. Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. 2001 J. Biol. Chem. pmid:11032840
Kaneda T et al. Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor. 2000 J. Immunol. pmid:11035059
Fata JE et al. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. 2000 Cell pmid:11051546
Miyamoto N et al. Spindle-shaped cells derived from giant-cell tumor of bone support differentiation of blood monocytes to osteoclast-like cells. 2000 J. Orthop. Res. pmid:11052502
Kinpara K et al. Osteoclast differentiation factor in human osteosarcoma cell line. 2000 J Immunoassay pmid:11071251
Kong YY et al. Osteoprotegerin ligand: a regulator of immune responses and bone physiology. 2000 Immunol. Today pmid:11071528
Sakuma Y et al. Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype. 2000 Infect. Immun. pmid:11083800
Riggs BL The mechanisms of estrogen regulation of bone resorption. 2000 J. Clin. Invest. pmid:11086020
Lee ZH et al. Activation of c-Jun N-terminal kinase and activator protein 1 by receptor activator of nuclear factor kappaB. 2000 Mol. Pharmacol. pmid:11093794
Takami M et al. Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts. 2000 Endocrinology pmid:11108286
Gori F et al. The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. 2000 Endocrinology pmid:11108292
Miyamoto T et al. An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand. 2000 Blood pmid:11110710
Proposed standard nomenclature for new tumor necrosis factor members involved in the regulation of bone resorption. The American Society for Bone and Mineral Research President's Committee on Nomenclature. 2000 Bone pmid:11113385
Takayanagi H et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. 2000 Nature pmid:11117749
Mancini L et al. Modulation of the effects of osteoprotegerin (OPG) ligand in a human leukemic cell line by OPG and calcitonin. 2000 Biochem. Biophys. Res. Commun. pmid:11118297

Table of Content